GC Green Cross Secures Product Approval for Hunter Syndrome Treatment in India and Taiwan
Hunterase IV Approved in 14 Countries Worldwide
"Expanding Presence in the Global Rare Disease Treatment Market"
GC Green Cross announced on August 24 that its Hunter syndrome treatment 'Hunterase IV' has obtained product approval from the Central Drugs Standard Control Organization (CDSCO) of India and the Taiwan Food and Drug Administration (TFDA). Additionally, the intraventricular administration formulation 'Hunterase ICV' has also been approved for product registration by the Taiwan TFDA.
With this, Hunterase IV has now been approved in a total of 14 countries worldwide, and Hunterase ICV has obtained product approval in a total of 4 countries.
India has a low rate of patients receiving existing treatments, making it a market with high unmet medical needs and significant growth potential. Taiwan, where both the IV and ICV formulations have received approval, is considered a country with excellent market accessibility due to its well-established early screening and patient support systems for Hunter syndrome.
GC Green Cross plans to further expand its presence in the global rare disease treatment market moving forward.
Hot Picks Today
"Two Spend 500,000 Won in a Flash, Yet Wait Two Hours?" ... 'Dreamland' Shunned by Kids and Foreign Tourists
- The Era of Getting 200 Million Won After 30 Years Is Over... A Japanese Bank's "Perpetual Department Head" Who Just Clocked In Cries Out
- Spain Hit by Its Worst Tragedy... Lee Kangin, Moreno and Real Madrid Join Soccer World in Mourning
- They Said, “Make It Your Home for Life” - Then Suddenly Kicked 200 Passengers Off... What Happened to the Around-the-World Cruise?
- "130 Rice Bowls Sold Out in a Day"... 'Unfiltered Face' Adds 8 Million Won to Night Market Sales: China's Bungeunwoo
Lee Jaewoo, Head of Development at GC Green Cross, said, "We will continue to do our best to help improve patients’ quality of life."
© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.